Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05689983 · ClinicalTrials.gov registry record · Phase 1
Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers
A Phase 1 study of Asthma in Children and Nonadherence, Medication, sponsored by Washington University School of Medicine.
- Active
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05689983 is a Phase 1 study of Asthma in Children and Nonadherence, Medication that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 40 participants, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05689983, a Phase 1 study of Asthma in Children and Nonadherence, Medication, is active but no longer recruiting, sponsored by Washington University School of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Inhaler nonadherence is a common problem that has been estimated to account for approximately 60% of all asthma-related hospitalizations. Unfortunately, prior interventions to improve inhaler nonadherence have shown a lack of long-term success. This study proposes to assess the problem of non-adherence using a D\&I research lens while testing a new inhaler approach to potentially ameliorate the detrimental consequences of maintenance inhaler nonadherence.
Conditions Studied
Interventions
- DRUG Maintenance ICS and Symptom Driven SABA
- DRUG Symptom-driven budesonide/formoterol combination
Study Locations (1)
Missouri
- Washington University in St. Louis School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2025-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05689983
The ClinicalTrials.gov registry entry for NCT05689983 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (80% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Asthma in Children appearing as the primary indexed condition, and to 2 interventions - of which Maintenance ICS and Symptom Driven SABA is the first listed.
NCT05689983 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05689983 about?
NCT05689983 is a clinical study titled "Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers". Inhaler nonadherence is a common problem that has been estimated to account for approximately 60% of all asthma-related hospitalizations. Unfortunately, prior interventions to improve inhaler nonadherence have shown a lack of long-term success. This study proposes to assess the problem of non-adhere...
What is the current status of trial NCT05689983?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2022-04-01. Estimated completion is 2025-12-01.
What conditions does trial NCT05689983 study?
This clinical trial studies the following conditions: Asthma in Children, Nonadherence, Medication.
What interventions are being tested in trial NCT05689983?
The interventions under investigation include: Maintenance ICS and Symptom Driven SABA (DRUG), Symptom-driven budesonide/formoterol combination (DRUG).
Who is sponsoring clinical trial NCT05689983?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05689983 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
Wearable Electronic Breath Sound Sensing Device
RECRUITING
-
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
RECRUITING · NA
-
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.